Appendix Table 2.
Medication Use, by Examination*
Medication | Baseline†
|
Ever Throughout Study‡
|
||
---|---|---|---|---|
Men | Women | Men | Women | |
Aspirin§ | 546 (27.84) | 484 (21.36) | 1132 (57.73) | 1214 (53.57) |
| ||||
Antihypertensive | 642 (32.74) | 821 (36.23) | 1142 (58.24) | 1362 (60.11) |
| ||||
Lipid-lowering|| | 308 (15.71) | 348 (15.36) | 855 (43.60) | 1009 (44.53) |
| ||||
Any | 1031 (52.58) | 1197 (52.82) | 1563 (79.70) | 1866 (82.35) |
| ||||
None | 930 (47.42) | 1069 (47.18) | 398 (20.30) | 400 (17.65) |
Values are numbers (percentages).
Examination 1.
Observed medication use any time during the study but before an event when applicable. Includes participants with missing data on risk factors.
Regular use.
Lipid-lowering therapy included a statin in 92.5% of participants at baseline and 94.0% of participants ever throughout the study.